303 related articles for article (PubMed ID: 11929208)
1. Duchenne muscular dystrophy.
Sussman M
J Am Acad Orthop Surg; 2002; 10(2):138-51. PubMed ID: 11929208
[TBL] [Abstract][Full Text] [Related]
2. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
Alman BA; Raza SN; Biggar WD
J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877
[TBL] [Abstract][Full Text] [Related]
3. Lower extremity joint contracture according to ambulatory status in children with Duchenne muscular dystrophy.
Choi YA; Chun SM; Kim Y; Shin HI
BMC Musculoskelet Disord; 2018 Aug; 19(1):287. PubMed ID: 30111310
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
Balaban B; Matthews DJ; Clayton GH; Carry T
Am J Phys Med Rehabil; 2005 Nov; 84(11):843-50. PubMed ID: 16244521
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
Wong BL; Christopher C
J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
[TBL] [Abstract][Full Text] [Related]
8. Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
Merlini L; Cecconi I; Parmeggiani A; Cordelli DM; Dormi A
Acta Myol; 2020 Dec; 39(4):200-206. PubMed ID: 33458575
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up.
Lebel DE; Corston JA; McAdam LC; Biggar WD; Alman BA
J Bone Joint Surg Am; 2013 Jun; 95(12):1057-61. PubMed ID: 23783200
[TBL] [Abstract][Full Text] [Related]
10. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.
Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H;
J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hand orthoses in Duchenne muscular dystrophy.
Weichbrodt J; Eriksson BM; Kroksmark AK
Disabil Rehabil; 2018 Nov; 40(23):2824-2832. PubMed ID: 28687062
[TBL] [Abstract][Full Text] [Related]
12. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of Duchenne muscular dystrophy.
Manzur AY; Kinali M; Muntoni F
Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary function and clinical correlation in DMD.
Mayer OH
Paediatr Respir Rev; 2019 Apr; 30():13-15. PubMed ID: 31130422
[TBL] [Abstract][Full Text] [Related]
15. Prednisone therapy in Becker's muscular dystrophy.
Johnsen SD
J Child Neurol; 2001 Nov; 16(11):870-1. PubMed ID: 11732779
[TBL] [Abstract][Full Text] [Related]
16. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
Houde S; Filiatrault M; Fournier A; Dubé J; D'Arcy S; Bérubé D; Brousseau Y; Lapierre G; Vanasse M
Pediatr Neurol; 2008 Mar; 38(3):200-6. PubMed ID: 18279756
[TBL] [Abstract][Full Text] [Related]
17. Deflazacort treatment of Duchenne muscular dystrophy.
Biggar WD; Gingras M; Fehlings DL; Harris VA; Steele CA
J Pediatr; 2001 Jan; 138(1):45-50. PubMed ID: 11148511
[TBL] [Abstract][Full Text] [Related]
18. Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center.
Marden JR; Freimark J; Yao Z; Signorovitch J; Tian C; Wong BL
J Comp Eff Res; 2020 Feb; 9(3):177-189. PubMed ID: 31922454
[No Abstract] [Full Text] [Related]
19. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy.
Papa R; Madia F; Bartolomeo D; Trucco F; Pedemonte M; Traverso M; Broda P; Bruno C; Zara F; Minetti C; Fiorillo C
Pediatr Neurol; 2016 Feb; 55():58-63. PubMed ID: 26718981
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
